REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $45,176,000 | +8.3% | 2,611,325 | +11.1% | 0.02% | 0.0% |
| Q1 2014 | $41,711,000 | +48.6% | 2,351,225 | +53.3% | 0.02% | +42.9% |
| Q4 2013 | $28,073,000 | -20.6% | 1,534,025 | +16.3% | 0.01% | -26.3% |
| Q3 2013 | $35,344,000 | +80.0% | 1,318,800 | +23.9% | 0.02% | +72.7% |
| Q2 2013 | $19,631,000 | – | 1,064,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $8,096,000 | 1.86% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,353,000 | 0.56% |
| RTW INVESTMENTS, LP | 229,364 | $1,640,000 | 0.48% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 182,500 | $1,305,000 | 0.41% |
| GENERAL AMERICAN INVESTORS CO INC | 601,553 | $4,301,000 | 0.35% |
| Baker Brothers Advisors | 1,955,944 | $13,985,000 | 0.12% |
| CQS Cayman LP | 240,000 | $1,716,000 | 0.10% |
| Gruss Capital Management LP | 304,000 | $2,174,000 | 0.08% |
| J. Goldman & Co LP | 101,881 | $728,000 | 0.04% |
| Squarepoint Ops LLC | 18,800 | $134,000 | 0.04% |